The risk of renal impairment in hormone-refractory prostate cancer patients with bone metastases treated with zoledronic acid.

The risk of renal impairment in hormone-refractory prostate cancer patients with bone metastases treated with zoledronic acid.

Item
http://www.wikidata.org/entity/Q36740442
Pharmacokinetics and tolerability of zibotentan (ZD4054) in subjects with hepatic or renal impairment: two open-label comparative studiesEvolving role of bone biomarkers in castration-resistant prostate cancer.Meta-analysis comparing denosumab and zoledronic acid for treatment of bone metastases in patients with advanced solid tumours.Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists.Clinical efficacy and safety of zoledronic acid in prostate and breast cancer.Long-term safety of monthly zoledronic acid therapy beyond 1 year in patients with advanced cancer involving bone (LoTESS): A multicentre prospective phase 4 study.Healthcare resource use and costs associated with renal impairment in US patients with bone metastases from solid tumors.Dosing related effects of zoledronic acid on bone markers and creatinine clearance in patients with multiple myeloma and metastatic breast cancer.Risk of renal failure in cancer patients with bone metastasis treated with renally adjusted zoledronic acid.Management of the side effects of androgen deprivation therapy in men with prostate cancer
P2860

The risk of renal impairment in hormone-refractory prostate cancer patients with bone metastases treated with zoledronic acid.

Item
http://www.wikidata.org/entity/Q36740442
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The risk of renal impairment i ...... treated with zoledronic acid.
@ast
The risk of renal impairment i ...... treated with zoledronic acid.
@en
type
label
The risk of renal impairment i ...... treated with zoledronic acid.
@ast
The risk of renal impairment i ...... treated with zoledronic acid.
@en
prefLabel
The risk of renal impairment i ...... treated with zoledronic acid.
@ast
The risk of renal impairment i ...... treated with zoledronic acid.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
The risk of renal impairment i ...... s treated with zoledronic acid
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698